(Q34035750)

English

Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia (English)

1 reference

Europe PubMed Central

30 July 2017

1 reference

based on heuristic

inferred from title

acute promyelocytic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Peter Westervelt

1

1 reference

Europe PubMed Central

30 July 2017

Jessica L Pollock

2

1 reference

Europe PubMed Central

30 July 2017

Kristie M Oldfather

3

1 reference

Europe PubMed Central

30 July 2017

Matthew J Walter

4

1 reference

Europe PubMed Central

30 July 2017

Margaret K Ma

5

1 reference

Europe PubMed Central

30 July 2017

Anthony Williams

6

1 reference

Europe PubMed Central

30 July 2017

John F DiPersio

7

1 reference

Europe PubMed Central

30 July 2017

Timothy J Ley

8

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

20 June 2002

1 reference

Europe PubMed Central

30 July 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

30 July 2017

99

1 reference

Europe PubMed Central

30 July 2017

9468-9473

1 reference

Europe PubMed Central

30 July 2017

14

1 reference

Europe PubMed Central

30 July 2017

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

HLA class I in acute promyelocytic leukemia (APL): possible correlation with clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Proto-oncogene PML controls genes devoted to MHC class I antigen presentation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Lack of T-cell-mediated recognition of the fusion region of the pml/RAR-alpha hybrid protein by lymphocytes of acute promyelocytic leukemia patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

All-trans-retinoic acid in acute promyelocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

A PMLRARalpha transgene initiates murine acute promyelocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

A program package for simulation and parameter estimation in pharmacokinetic systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

5 July 2018

Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.132657799

21 January 2018

Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.132657799

21 January 2018

Expression of costimulatory molecules in human leukemias.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

29 October 2018

Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

29 October 2018

Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=123164

29 October 2018

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/12077315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12077315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/12077315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/12077315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/12077315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12077315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells: implications for adoptive immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12077315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.132657799

1 reference

Europe PubMed Central

30 July 2017

2002PNAS...99.9468W

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34035750&oldid=1954359613"